Adult acute lymphoblastic leukemia: concepts and strategies
- PMID: 20101737
- PMCID: PMC5345568
- DOI: 10.1002/cncr.24862
Adult acute lymphoblastic leukemia: concepts and strategies
Abstract
Acute lymphoblastic leukemia (ALL), a clonal expansion of hematopoietic blasts, is a highly heterogeneous disease comprising many entities for which distinct treatment strategies are pursued. Although ALL is a success story in pediatric oncology, results in adults lag behind those in children. An expansion of new drugs, more reliable immunologic and molecular techniques for the assessment of minimal residual disease, and efforts at more precise risk stratification are generating new aspects of adult ALL therapy. For this review, the authors summarized pertinent and recent literature on ALL biology and therapy, and they discuss current strategies and potential implications of novel approaches to the management of adult ALL. Cancer 2010. (c) 2010 American Cancer Society.
Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURES
Supported by grant CA21765 from the National Institutes of Health and by the American Lebanese Syrian Associated Charities.
Figures
References
-
- Pui CH, Robison L, Look AT. Acute lymphoblastic leukemia. Lancet. 2008;354:166–178. - PubMed
-
- Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2006;56:106–130. - PubMed
-
- Wartenberg D, Groves FD, Adelman AS. Acute lymphoblastic leukemia: epidemiology and etiology. In: Estey EH, Faderl S, Kantarjian H, editors. Acute Leukemias. 1. Berlin, Germany: Springer; 2008. pp. 77–93.
-
- Kinlen LJ. Infections and immune factors in cancer: the role of epidemiology. Oncogene. 2004;23:6341–6348. - PubMed
-
- Greaves M. Infection, immune responses and aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6:193–203. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
